Global Plasma Protease C1-inhibitor Treatment Market Research Report 2019

Table of Contents

Executive Summary

1 Plasma Protease C1-inhibitor Treatment Market Overview

• 1.1 Product Overview and Scope of Plasma Protease C1-inhibitor Treatment
• 1.2 Plasma Protease C1-inhibitor Treatment Segment by Drug Class
  • 1.2.1 Global Plasma Protease C1-inhibitor Treatment Production Growth Rate Comparison by Drug Class (2014-2025)
  • 1.2.2 C1-inhibitors
  • 1.2.3 Kallikrein Inhibitor (Kalbitor)
  • 1.2.4 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
• 1.3 Plasma Protease C1-inhibitor Treatment Segment by Application
  • 1.3.1 Plasma Protease C1-inhibitor Treatment Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Independent Pharmacies and Outlets
• 1.4 Global Plasma Protease C1-inhibitor Treatment Market by Region
  • 1.4.1 Global Plasma Protease C1-inhibitor Treatment Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
  • 1.4.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.4.7 India Status and Prospect (2014-2025)
• 1.5 Global Plasma Protease C1-inhibitor Treatment Market Size
  • 1.5.1 Global Plasma Protease C1-inhibitor Treatment Revenue (2014-2025)
  • 1.5.2 Global Plasma Protease C1-inhibitor Treatment Production (2014-2025)

2 Global Plasma Protease C1-inhibitor Treatment Market Competition by Manufacturers

• 2.1 Global Plasma Protease C1-inhibitor Treatment Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Plasma Protease C1-inhibitor Treatment Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Plasma Protease C1-inhibitor Treatment Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Plasma Protease C1-inhibitor Treatment Production Sites, Area Served, Product Types
• 2.5 Plasma Protease C1-inhibitor Treatment Market Competitive Situation and Trends
  • 2.5.1 Plasma Protease C1-inhibitor Treatment Market Concentration Rate
  • 2.5.2 Plasma Protease C1-inhibitor Treatment Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Plasma Protease C1-inhibitor Treatment Production Market Share by Regions

• 3.1 Global Plasma Protease C1-inhibitor Treatment Production Market Share by Regions
• 3.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Regions (2014-2019)
• 3.3 Global Plasma Protease C1-inhibitor Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Plasma Protease C1-inhibitor Treatment Production
  • 3.4.1 North America Plasma Protease C1-inhibitor Treatment Production Growth Rate (2014-2019)
  • 3.4.2 North America Plasma Protease C1-inhibitor Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Plasma Protease C1-inhibitor Treatment Production
  • 3.5.1 Europe Plasma Protease C1-inhibitor Treatment Production Growth Rate (2014-2019)
  • 3.5.2 Europe Plasma Protease C1-inhibitor Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Plasma Protease C1-inhibitor Treatment Production (2014-2019)
  • 3.6.1 China Plasma Protease C1-inhibitor Treatment Production Growth Rate (2014-2019)
  • 3.6.2 China Plasma Protease C1-inhibitor Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Plasma Protease C1-inhibitor Treatment Production (2014-2019)
  • 3.7.1 Japan Plasma Protease C1-inhibitor Treatment Production Growth Rate (2014-2019)
  • 3.7.2 Japan Plasma Protease C1-inhibitor Treatment Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Plasma Protease C1-inhibitor Treatment Consumption by Regions

• 4.1 Global Plasma Protease C1-inhibitor Treatment Consumption by Regions
• 4.2 North America Plasma Protease C1-inhibitor Treatment Consumption (2014-2019)
• 4.3 Europe Plasma Protease C1-inhibitor Treatment Consumption (2014-2019)
• 4.4 China Plasma Protease C1-inhibitor Treatment Consumption (2014-2019)
• 4.5 Japan Plasma Protease C1-inhibitor Treatment Consumption (2014-2019)

5 Global Plasma Protease C1-inhibitor Treatment Production, Revenue, Price Trend by Type

• 5.1 Global Plasma Protease C1-inhibitor Treatment Production Market Share by Type (2014-2019)
• 5.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2014-2019)
• 5.3 Global Plasma Protease C1-inhibitor Treatment Price by Type (2014-2019)
• 5.4 Global Plasma Protease C1-inhibitor Treatment Production Growth by Type (2014-2019)

6 Global Plasma Protease C1-inhibitor Treatment Market Analysis by Applications

• 6.1 Global Plasma Protease C1-inhibitor Treatment Consumption Market Share by Application (2014-2019)
• 6.2 Global Plasma Protease C1-inhibitor Treatment Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Plasma Protease C1-inhibitor Treatment Business

• 7.1 Shire plc
  • 7.1.1 Shire plc Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
  • 7.1.2 Plasma Protease C1-inhibitor Treatment Product Introduction, Application and Specification
  • 7.1.3 Shire plc Plasma Protease C1-inhibitor Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 CSL Limited
  • 7.2.1 CSL Limited Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
  • 7.2.2 Plasma Protease C1-inhibitor Treatment Product Introduction, Application and Specification
  • 7.2.3 CSL Limited Plasma Protease C1-inhibitor Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Sanquin
  • 7.3.1 Sanquin Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
  • 7.3.2 Plasma Protease C1-inhibitor Treatment Product Introduction, Application and Specification
  • 7.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Pharming Group N.V.
  • 7.4.1 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
  • 7.4.2 Plasma Protease C1-inhibitor Treatment Product Introduction, Application and Specification
  • 7.4.3 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served

8 Plasma Protease C1-inhibitor Treatment Manufacturing Cost Analysis

• 8.1 Plasma Protease C1-inhibitor Treatment Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Plasma Protease C1-inhibitor Treatment
• 8.4 Plasma Protease C1-inhibitor Treatment Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Plasma Protease C1-inhibitor Treatment Distributors List
• 9.3 Plasma Protease C1-inhibitor Treatment Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Plasma Protease C1-inhibitor Treatment Market Forecast

• 11.1 Global Plasma Protease C1-inhibitor Treatment Production, Revenue Forecast
  • 11.1.1 Global Plasma Protease C1-inhibitor Treatment Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Plasma Protease C1-inhibitor Treatment Price and Trend Forecast (2019-2025)
• 11.2 Global Plasma Protease C1-inhibitor Treatment Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Plasma Protease C1-inhibitor Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Plasma Protease C1-inhibitor Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Plasma Protease C1-inhibitor Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Plasma Protease C1-inhibitor Treatment Production, Revenue Forecast (2019-2025)
• 11.3 Global Plasma Protease C1-inhibitor Treatment Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Plasma Protease C1-inhibitor Treatment Consumption Forecast (2019-2025)
  • 11.3.2 Europe Plasma Protease C1-inhibitor Treatment Consumption Forecast (2019-2025)
  • 11.3.3 China Plasma Protease C1-inhibitor Treatment Consumption Forecast (2019-2025)
  • 11.3.4 Japan Plasma Protease C1-inhibitor Treatment Consumption Forecast (2019-2025)
• 11.4 Global Plasma Protease C1-inhibitor Treatment Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Plasma Protease C1-inhibitor Treatment Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List